<?xml version="1.0" encoding="UTF-8"?>
<p id="p0110">A pseudotyped-lentiviral-vector-based neutralization assay to measure specific NAbs in plasma from recovered patients with SARS-CoV-2 showed variations in NAbs titers, approximately 30% of patients did not develop high NAbs titers after infection [
 <xref rid="bb0305" ref-type="bibr">61</xref>]. These variations are associated with age, lymphocyte count, and C reactive protein levels in blood, suggesting that other components from plasma contribute to the recovery of these patients.
</p>
